High-dose therapy is given to multiple myeloma patients with similar clinical characteristics to those in conventional chemotherapy and improves survival in multiple myeloma: a retrospective analysis from a single centre
30th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/20th Meeting of the EBMT-Nurses-Group/3rd Meeting of the EBMT-Data-Management-Group, Barcelona, İspanya, 28 - 31 Mart 2004, cilt.33, (Özet Bildiri)